1.5500
+0.1500
+(10.71%)
At close: January 10 at 9:31:33 AM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-2,412.4900
-3,167.7820
-3,706.1260
-119.9550
-9.8470
Investing Cash Flow
-154.9620
-7.2440
-59.9920
--
--
Financing Cash Flow
2,613.7000
1,997.5000
4,457.7570
1,373.0920
--
End Cash Position
683.8360
928.6810
2,106.2080
1,414.5690
151.5850
Interest Paid Supplemental Data
5.0530
4.0030
2.2680
--
--
Capital Expenditure
-154.9620
-7.2440
-59.9920
--
--
Issuance of Capital Stock
2,462.5000
1,997.5000
4,457.7570
--
--
Free Cash Flow
-2,567.4520
-3,175.0260
-3,766.1180
-119.9550
-9.8470
12/31/2020 - 10/24/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ESLAW Estrella Immunopharma, Inc.
0.0910
-0.11%
SBMFF Sino Biopharmaceutical Limited
0.4110
0.00%
INTI Inhibitor Therapeutics, Inc.
0.0600
0.00%
MBXBF Microbix Biosystems Inc.
0.2978
-1.03%
MRES Institute of Biomedical Research Corp.
0.0230
+74.24%
ACHFF Arch Biopartners Inc.
1.3300
0.00%
EMMA Emmaus Life Sciences, Inc.
0.0140
0.00%
KRBP Kiromic BioPharma, Inc.
0.9250
0.00%
ESLA Estrella Immunopharma, Inc.
1.1900
+6.25%
ATNFW 180 Life Sciences Corp.
0.0100
-4.76%